ANTEOTECH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.022 AUD | -4.35% |
|
-2.22% | -38.89% |
| May. 02 | AnteoTech Extends Closing Date of Share Purchase Plan | MT |
| Apr. 08 | Anteotech Seeks to Raise AU$6 Million From Share Placement; Shares Fall 26% | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 761K 502K | Sales 2023 | 366K 241K | Capitalization | 82M 54.09M |
|---|---|---|---|---|---|
| Net income 2022 | -10M -6.6M | Net income 2023 | -12M -7.92M | EV / Sales 2022 | 158 x |
| Net cash position 2022 | 9.07M 5.98M | Net cash position 2023 | 1.41M 933K | EV / Sales 2023 | 220 x |
| P/E ratio 2022 |
-12
x | P/E ratio 2023 |
-6.33
x | Employees | 99 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.47% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.35% | ||
| 1 week | -2.22% | ||
| Current month | +4.76% | ||
| 3 months | -31.25% | ||
| 6 months | -12.00% | ||
| Current year | -38.89% |
1 week
0.02
0.02
1 month
0.020.02
Current year
0.020.04
1 year
0.020.06
3 years
0.020.42
5 years
0.010.50
10 years
0.010.50
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | - | 08-12-31 | |
David Radford
CEO | Chief Executive Officer | - | 22-10-03 |
Andrew Cook
DFI | Director of Finance/CFO | - | 23-08-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 21-08-31 | |
| Director/Board Member | - | 21-08-31 | |
David Radford
CEO | Chief Executive Officer | - | 22-10-03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 0.022 | -4.35% | 122 583 |
| 24-05-10 | 0.023 | 0.00% | 5,253,389 |
| 24-05-09 | 0.023 | +9.52% | 973,480 |
| 24-05-08 | 0.021 | 0.00% | 2,762,110 |
| 24-05-07 | 0.021 | -6.67% | 1,547,985 |
Delayed Quote Australian S.E., May 13, 2024 at 02:10 am EDT
More quotes
AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Companyâs lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.
Calendar
2024-08-26
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.89% | 36.58M | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| +48.77% | 41.85B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B |
- Stock Market
- Equities
- ADO Stock
